Skip to main content
. 2018 Aug 28;9(9):851. doi: 10.1038/s41419-018-0937-7

Fig. 8. The prognostic value of DSCR8 and miR-485-5p expression in HCC patients.

Fig. 8

HCC patients in high DSCR8 group had poorer 5-year overall survival (a) and disease-free survival (b). MiR-485-5p high-expressing HCC patients showed better 5-year overall survival (c) and disease-free survival (d) compared to miR-485-5p low-expressing cases. For each cohort, different subgroups were sorted according to the median expression levels of DSCR8 and miR-485-5p